X
Xponance Portfolio holdings
AUM
$12B
1-Year Return
25.85%
This Quarter Return
+16.51%
1 Year Return
+25.85%
3 Year Return
+121.93%
5 Year Return
+206.65%
10 Year Return
+301.62%
AUM
$12B
AUM Growth
+$1.63B
(+16%)
Cap. Flow
+$359M
Cap. Flow
% of AUM
3%
Top 10 Holdings %
Top 10 Hldgs %
39.3%
Holding
1,552
New
107
Increased
841
Reduced
558
Closed
44
Top Buys
| 1 |
NVIDIA
NVDA
|
$42.5M |
| 2 |
Apple
AAPL
|
$40.7M |
| 3 |
Microsoft
MSFT
|
$39.9M |
| 4 |
GE Aerospace
GE
|
$22.6M |
| 5 |
AbbVie
ABBV
|
$20M |
Top Sells
| 1 |
Amazon
AMZN
|
$22.1M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$21.8M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$19M |
| 4 |
Salesforce
CRM
|
$16.1M |
| 5 |
Merck
MRK
|
$15.5M |
Sector Composition
| 1 | Technology | 37.5% |
| 2 | Financials | 11.85% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Communication Services | 10.18% |
| 5 | Healthcare | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDN
1451
Brandywine Realty Trust
BDN
$749M
| $57K | ﹤0.01% |
13,296
+575
| +5% | +$2.47K |
|
|
RC
1452
Ready Capital
RC
$700M
| $56.6K | ﹤0.01% |
12,948
+1,019
| +9% | +$4.45K |
|
1453
Microvast
MVST
$819M
| $56.3K | ﹤0.01% |
+15,513
| New | +$56.3K |
|
1454
LG Display
LPL
$4.48B
| $55.8K | ﹤0.01% |
16,317
| – | – |
|
1455
Agilon Health
AGL
$501M
| $54.5K | ﹤0.01% |
23,680
+26
| +0.1% | +$60 |
|
1456
indie Semiconductor
INDI
$850M
| $53.8K | ﹤0.01% |
15,126
+3,018
| +25% | +$10.7K |
|
1457
Xeris Biopharma Holdings
XERS
$1.27B
| $53.5K | ﹤0.01% |
11,460
+1,141
| +11% | +$5.33K |
|
1458
Nokia
NOK
$24.7B
| $53.4K | ﹤0.01% |
10,306
+192
| +2% | +$995 |
|
1459
Blend Labs
BLND
$947M
| $53.4K | ﹤0.01% |
16,169
-2,039
| -11% | -$6.73K |
|
1460
Lifestance Health
LFST
$2.13B
| $53.1K | ﹤0.01% |
10,269
-51
| -0.5% | -$264 |
|
1461
NIO
NIO
$13.8B
| $48.4K | ﹤0.01% |
14,098
+3,761
| +36% | +$12.9K |
|
1462
ImmunityBio
IBRX
$2.26B
| $47K | ﹤0.01% |
17,786
+6,765
| +61% | +$17.9K |
|
|
ETWO
1463
DELISTED
E2open Parent Holdings
ETWO
| $45.4K | ﹤0.01% |
14,057
-1,288
| -8% | -$4.16K |
|
1464
New Fortress Energy
NFE
$644M
| $43.7K | ﹤0.01% |
+13,155
| New | +$43.7K |
|
1465
Altice USA
ATUS
$1.09B
| $43K | ﹤0.01% |
+20,082
| New | +$43K |
|
1466
Gannett
GCI
$603M
| $42.5K | ﹤0.01% |
11,862
+474
| +4% | +$1.7K |
|
1467
Gerdau
GGB
$6.15B
| $42.3K | ﹤0.01% |
14,495
+335
| +2% | +$978 |
|
1468
Nordic American Tanker
NAT
$684M
| $41.7K | ﹤0.01% |
15,867
-2,704
| -15% | -$7.11K |
|
|
EU
1469
enCore Energy
EU
$434M
| $40.7K | ﹤0.01% |
14,215
+1,039
| +8% | +$2.97K |
|
1470
Ambev
ABEV
$34.1B
| $39.3K | ﹤0.01% |
16,298
+196
| +1% | +$472 |
|
1471
CEMIG Preferred Shares
CIG
$5.84B
| $37.7K | ﹤0.01% |
19,259
+283
| +1% | +$555 |
|
1472
Nuvation Bio
NUVB
$1.17B
| $37.7K | ﹤0.01% |
19,334
+6,207
| +47% | +$12.1K |
|
1473
Opko Health
OPK
$1.1B
| $36.9K | ﹤0.01% |
27,949
+4,191
| +18% | +$5.53K |
|
1474
Arbutus Biopharma
ABUS
$753M
| $35.9K | ﹤0.01% |
11,622
+745
| +7% | +$2.3K |
|
1475
Relay Therapeutics
RLAY
$690M
| $35.5K | ﹤0.01% |
+10,273
| New | +$35.5K |
|